PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Hypertension: Disease overview • Key buying criteria • Burden of disease • Detection methods for ambulatory blood pressure monitor PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Ambulatory blood pressure monitoring: An overview • Advantages and disadvantages of ambulatory blood pressure monitors • Comparison between ambulatory blood pressure monitoring and home-based blood pressure monitoring • Guidelines for ambulatory blood pressure monitoring systems PART 07: Geographical segmentation • Ambulatory blood pressure monitoring systems market in Americas • Ambulatory blood pressure monitoring systems market in EMEA • Ambulatory blood pressure monitoring systems market in APAC PART 08: Market drivers • Incidence of hypertension • Preference for home care monitoring devices • Favorable reimbursement scenario in Europe • Online marketing strategies PART 09: Impact of drivers PART 10: Market challenges • Limitations of ambulatory blood pressure monitoring systems • Pricing pressure and counterfeit products • Availability of alternative technologies • Intense competition among vendors PART 11: Impact of drivers and challenges PART 12: Market trends • Shift from physician-centered to patient-centered model • Product bundling strategy • Use of multiparameter medical devices • Development of wireless ambulatory blood pressure monitors PART 13: Vendor landscape • Competitive scenario • Key news • Key vendor profiles • A&D • GE Healthcare • Microlife • Omron Healthcare • Schiller • Spacelabs Healthcare • SunTech Medical • Welch Allyn • Other prominent vendors PART 14: Appendix • List of abbreviations PART 15: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Types of blood pressure monitoring systems Exhibit 03: Pathophysiology of hypertension Exhibit 04: Treatment algorithm for hypertension Exhibit 05: Prevalence of PAH by cause 2015 Exhibit 06: Projected prevalence of CVDs among US population 2010-2030 Exhibit 07: Percentage of hypertension prevalence among US population 2010-2030 Exhibit 08: Key buying criteria for hypertension drugs Exhibit 09: Projected direct and indirect burden of hypertension on Americans 2010-2030 ($ billions) Exhibit 10: Projected mortality trend for CVDs globally 2015 and 2030 Exhibit 11: Ambulatory blood pressure monitoring Exhibit 12: Detection methods for ambulatory blood pressure monitoring Exhibit 13: Applications of ambulatory blood pressure monitors Exhibit 14: Limitations of ambulatory blood pressure monitoring Exhibit 15: Global ambulatory blood pressure monitoring systems market 2015-2020 ($ millions) Exhibit 16: Five forces analysis Exhibit 17: Difference between ambulatory blood pressure monitors and home-based blood pressure monitors Exhibit 18: Barriers and facilitators of ambulatory blood pressure monitoring systems Exhibit 19: Global ambulatory blood pressure monitoring systems market segmentation by geography 2015 Exhibit 20: Global ambulatory blood pressure monitoring systems market segmentation by geography 2020 Exhibit 21: Global ambulatory blood pressure monitoring systems market segmentation by geography 2015-2020 Exhibit 22: Ambulatory blood pressure monitoring systems market in Americas 2015-2020 ($ millions) Exhibit 23: Ambulatory blood pressure monitoring systems market in EMEA 2015-2020 ($ millions) Exhibit 24: Ambulatory blood pressure monitoring systems market in APAC 2015-2020 ($ millions) Exhibit 25: Impact of drivers Exhibit 26: Impact of drivers and challenges Exhibit 27: A&D: Product portfolio Exhibit 28: A&D: Key takeaways Exhibit 29: GE Healthcare: Key takeaways Exhibit 30: Microlife: Product portfolio Exhibit 31: Microlife: Key takeaways Exhibit 32: Omron Healthcare: Product portfolio Exhibit 33: Omron Healthcare: Key takeaways Exhibit 34: Schiller: Product portfolio Exhibit 35: Schiller: Key takeaways Exhibit 36: Spacelabs Healthcare: Product portfolio Exhibit 37: Spacelabs Healthcare: Key takeaways Exhibit 38: SunTech Medical: Product portfolio Exhibit 39: SunTech Medical: Key takeaways Exhibit 40: Welch Allyn: Product portfolio Exhibit 41: Welch Allyn: Key takeaways Exhibit 42: Other prominent vendors

A&D, Omron Healthcare, Spacelabs Healthcare, SunTech Medical, Welch Allyn, American Diagnostic, Beurer, Bosch + Sohn, Citizen Systems Japan, GE Healthcare, Geratherm Medical, HONSUN, Microlife, Norditalia Group, Riester, Rossmax International, Schiller, Suzuken, Vasomedical, Withings.